Opportunistic infections in individuals with HIV infection and relationship with the use of anti-retroviral therapy;Infecções oportunistas em indivíduos com infecção pelo HIV e relação com uso de terapia antirretroviral

Acta Scientiarum - Health Sciences

Volumn 32, Issue 2, 2010, Pages 141-145

  Fagundes, Vinicius Henrique Veraldo ^a   Oliveira, João Henrique Torquato ^a   Vieira, Sandra ^a   Junior, Miguel Spack ^a   Pupulin, Áurea Regina Telles ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

AIDS; HAART; HIV; Opportunist infections

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; QUESTIONNAIRE; SOCIOECONOMICS;

EID: 78449268691     PISSN: 16799291     EISSN: 18078648     Source Type: Journal    
DOI: 10.4025/actascihealthsci.v32i2.4508     Document Type: Article

References (15)

1. BRITO, A. M.; CASTILHO, E. A.; SZWARCWALD, C. L. AIDS e infecção pelo HIV no Brasil: uma epidemia multifacetada. Revista da Sociedade Brasileira de Medicina Tropical, v. 34, n. 2., p. 207-217, 2001.
2. CASSEB, J.; PEREIRA, L. C.; SILVA, G. L.; MEDEIROS, L. A. Decreasing mortality and morbidity in adults AIDS patients from 1995 to 1997 in São Paulo, Brazil. AIDS patient care and STDs, v. 13, n. 4, p. 213-214, 1999.
3. CHEQUER, P.; HEARST, N.; HUDES, E. S.; CASTILHO, E.; RUTHERFORD, G.; LOURES, L.; RODRIGUES, L. Determinants of survival in adult Brazilian AIDS patients, 1982-1989. AIDS, v. 6, n. 5, p. 483-487, 1992.
4. CHIESI, A.; MOCROFT, A.; DALLY, L. G.; MILLER, V.; KATLAMA, C.; LEDERGERBER, B.; PEDERSEN, C.; PHILLIPS, N. A.; ARCIERI, R.; LUNDGREN, J. D. Regional survival differences across Europr in HIV-positive people: the EuroSIDA study. AIDS, v. 13, n. 16, p. 2281-2288, 1999.
5. CONTI, S.; MASOCCO, M.; PEZZOTI, P.; TOCCACELI, V.; VICHI, M.; BOROS, S.; URCIOLI, R.; VALDARCHI, C.; REZZA, G. Diferential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS- defining illnesses. JAIDS, v. 25, n. 5, p. 451-458, 2000.
6. DETELS, R.; MUÑOZ, A.; MCFARLANE, G.; KINGSLEY, L. A.; MARGOLICK, J. B.; GIORGI, J.; SCHRAGER, L. K.; PHAIR, J. P. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA, v. 280, n. 17, p. 1497-1503, 1998.
7. FORREST, D.; SEMINARI, E.; HOGG, R. S. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clinical Infectious Diseases, v. 27, n. 6, p.1379-85, 1998.
8. FRIEDLAND, G. H.; WILLIAMS, A. Attaining higher goals in HIV treatment the central importance of adherense. AIDS, v. 13, n. 1, p. 561-72, 1999.
9. HOGG, R. S.; HEATH, K. V.; YIP, B.; CRAIB, K. J. P.; O'SHAUGHNESSY, M. O.; SCHECHTER, M. T.; MONTANER, J. S. G. Improved survival among following initiation of antiretroviral therapy. JAMA, v. 279, n. 5, p. 450-454, 1998.
10. KHANNA, N. HAART use in women with HIV and influence on cervical intraepithelial neoplasia: a clinical opinion. Journal of Lower Genital Tract Disease, v. 6, n. 2, p. 111-115, 2002.
11. KHOLOUD, P. Survival after introduction of HAART in people with known duration of HIV-1 infection. The Lancet, v. 355, n. 9210, p. 1158-1159, 2000.
12. PALELLA, F.; DELANEY, K. M.; MOORMAN, A. C. Declining mortality among patients with advanced HIV infection. New England Journal of Medicine, v. 338, n. 13, p. 859, 1998.
13. PEZZOTI, P.; NAPOLI, P. A.; ACCIAI, S.; BOROS, S.; URCIUOLI, R.; LAZZERI, V.; REZZA, G. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. For the Tuscany AIDS Study Group AIDS, v. 13, n. 2, p. 249-255, 1999.
14. SENDI, P. P.; BUCHER, H. C.; CRAIG, B. A.; BATTEGAY, M. Estimating AIDS-free survival in a severely immunosuppressed asyntomatic HIV-infected population in the era of antiretroviral triple combination therapy. For the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, v. 20, n. 4, p. 377-381, 1999.
15. SETHI, A. K.; CELENTANO, D. D.; MOORE, R. D.; GALIANT, J. E. Association between to antiretroviral hterapy ande human immunodeficiency virus drug resistance. Clinical Infectious Diseases, v. 37, n. 4, p. 1112-1118, 2003.